Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Mayo Clinic
Rochester, Estados UnidosPublicacións en colaboración con investigadores/as de Mayo Clinic (7)
2021
-
Clinical effectiveness of olaparib monotherapy in germline BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: phase IIIb LUCY interim analysis
European Journal of Cancer, Vol. 152, pp. 68-77
-
Evaluation of multiple transcriptomic gene risk signatures in male breast cancer
npj Breast Cancer, Vol. 7, Núm. 1
2018
-
Characterization of male breast cancer: Results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Annals of Oncology, Vol. 29, Núm. 2, pp. 405-417
2011
-
p16 INK4a expression and breast cancer risk in women with atypical hyperplasia
Cancer Prevention Research, Vol. 4, Núm. 12, pp. 1953-1960
2010
-
Diagnostic utility of snail in metaplastic breast carcinoma
Diagnostic Pathology, Vol. 5, Núm. 1
2009
-
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells
Cancer Research, Vol. 69, Núm. 7, pp. 2887-2895
2008
-
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer
Journal of the National Cancer Institute, Vol. 100, Núm. 6, pp. 421-427